How Is Blood Screening Technology Improving Safety in North America?

Author : komal Galande | Published On : 10 Apr 2026

Executive Summary North America Blood Screening Market Size and Share Forecast

CAGR Value

The North America blood screening market size was valued at USD 1.08 billion in 2025 and is expected to reach USD 2.45 billion by 2033, at a CAGR of 10.80% during the forecast period

Competitive analysis performed in this North America Blood Screening Market report puts forth the moves of the key players in the North America Blood Screening Market industry, such as new product launches, expansions, agreements, joint ventures, partnerships, and recent acquisitions. Two of the most widely used techniques, namely SWOT analysis and Porter's Five Forces Analysis, have been applied while preparing this market report. This gathered data and information is characterized very neatly with the help of the most appropriate graphs, charts, or tables in the whole report. In this swiftly transforming industry, market research, or secondary research, is the best way to collect information quickly, and this keyword market research report is vital.

With the utilization of well-established tools and techniques in this North America Blood Screening report, complex market insights are twisted into a simpler version. Some of the competitor strategies can be named as new product launches, expansions, agreements, partnerships, joint ventures, and acquisitions. Market drivers and market restraints explained in this North America Blood Screening report aid businesses in getting an idea about the production strategy. This market report gives out the information about company profile, product specifications, capacity, production value, and market shares for each company for the year under the competitive analysis study.

Gain clarity on industry shifts, growth areas, and forecasts in our North America Blood Screening Market report. Get your copy:
https://www.databridgemarketresearch.com/reports/north-america-blood-screening-market

North America Blood Screening Market Review

Segments

- On the basis of product type, the North America blood screening market can be segmented into reagents & kits, instruments, software, and services. Reagents & kits segment is expected to dominate the market due to the high usage of these products in blood screening procedures.
- By technology, the market can be divided into nucleic acid amplification, western blotting, ELISA, rapid tests, and others. The nucleic acid amplification segment is anticipated to witness significant growth owing to its high sensitivity and specificity in detecting pathogens.
- Based on application, the market segments include blood transfusion, blood donation, disease screening, and others. The blood transfusion segment is projected to hold a considerable market share due to the increasing number of blood transfusions conducted worldwide.
- In terms of end-users, the market can be categorized into hospitals, blood banks, diagnostic centers, and others. The hospitals segment is expected to lead the market as hospitals are the primary healthcare settings where blood screening procedures are conducted.

Market Players

- Some of the key players operating in the North America blood screening market are Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Grifols, Siemens Healthineers, Ortho Clinical Diagnostics, bioMérieux SA, Beckman Coulter, Inc., and F. Hoffman-La Roche Ltd.
- These market players are focusing on strategic initiatives such as partnerships, collaborations, mergers, and acquisitions to strengthen their market position. Technological advancements and product innovations are also key strategies adopted by these players to enhance their product portfolios and cater to the evolving needs of the healthcare industry.
- The competitive landscape of the North America blood screening market is highly fragmented with the presence of several small and large players. Market players are investing significantly in research and development activities to launch innovative products and gain a competitive edge in the market.

The North America blood screening market is witnessing significant growth driven by various factors such as the rising prevalence of infectious diseases, increasing awareness about blood safety, and the growing demand for blood transfusions. One of the key trends shaping the market is the increasing adoption of advanced technologies for blood screening procedures. Nucleic acid amplification technology, in particular, is gaining traction due to its high sensitivity and specificity in detecting pathogens, thereby improving the accuracy of blood screening tests. This technological advancement is likely to revolutionize the blood screening process, leading to more efficient and reliable results.

Moreover, the market is characterized by a diverse range of product offerings, including reagents & kits, instruments, software, and services. The dominance of the reagents & kits segment can be attributed to their extensive usage in blood screening procedures, highlighting the importance of these products in ensuring the safety and quality of blood products. As the demand for blood transfusions continues to escalate globally, the blood transfusion segment is expected to maintain a significant market share, driven by the increasing number of blood transfusions being performed in healthcare settings.

In terms of market players, key companies such as Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific Inc. are leading the market through strategic initiatives aimed at strengthening their market position. Collaborations, partnerships, mergers, and acquisitions are common strategies adopted by these players to enhance their product portfolios and expand their market reach. Furthermore, continuous investments in research and development activities are enabling market players to launch innovative products, further fueling market growth and competition.

The competitive landscape of the North America blood screening market remains fragmented, with both small and large players vying for market share. This competitive scenario is driving intense innovation and technological advancements in the market, ultimately benefiting healthcare providers and patients with more advanced and accurate blood screening solutions. Overall, the North America blood screening market is poised for significant growth in the coming years, propelled by increasing healthcare expenditure, stringent regulatory guidelines, and the continuous evolution of screening technologies to meet the evolving needs of the healthcare industry.The North America blood screening market is characterized by a robust growth trajectory driven by several key factors. One of the primary drivers of market expansion is the escalating prevalence of infectious diseases, which has accentuated the need for efficient blood screening procedures to ensure the safety of blood products. Additionally, increasing awareness about blood safety standards among healthcare providers and the general population is fostering a conducive environment for the growth of the market. The rising demand for blood transfusions, fueled by a growing number of medical procedures and conditions requiring blood support, is further propelling market growth.

A notable trend shaping the market is the rapid adoption of advanced technologies for blood screening processes. Nucleic acid amplification technology, known for its high sensitivity and specificity in pathogen detection, is gaining traction within the market. This technology is revolutionizing blood screening tests by enhancing accuracy, thereby improving overall patient outcomes. As healthcare facilities prioritize the implementation of cutting-edge technologies to ensure precise screening results, the demand for nucleic acid amplification technology is expected to surge, driving market growth.

Key market players such as Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific Inc. are at the forefront of market leadership, leveraging strategic initiatives to fortify their market positions. Partnerships, collaborations, mergers, and acquisitions are pivotal strategies employed by these companies to expand their product portfolios and extend their market presence. Furthermore, continuous investments in research and development activities are enabling market players to introduce innovative products, catering to the evolving needs of healthcare providers and patients.

The competitive landscape of the North America blood screening market is marked by intense competition among a mix of small and large players. This competitive dynamic is fostering a culture of innovation and technological advancement within the market, ultimately benefiting healthcare stakeholders with more sophisticated and accurate blood screening solutions. The market is poised for substantial growth in the forthcoming years, driven by factors such as increasing healthcare expenditure, stringent regulatory frameworks, and the continual evolution of screening technologies to align with the evolving demands of the healthcare industry.

Uncover the company’s portion of market ownership
https://www.databridgemarketresearch.com/reports/north-america-blood-screening-market/companies

Structured Market Research Questions for North America Blood Screening Market

What is the present size of the global North America Blood Screening industry?
What annual growth rate is projected for the North America Blood Screening sector?
What are the main segment divisions in the North America Blood Screening Market report?
Who are the established players in the global North America Blood Screening Market?
What geographic areas are explored in the North America Blood Screening Market report?
Who are the leading manufacturers and service providers for North America Blood Screening Market?

Browse More Reports:

Global Hearth Market
Global Hemophagocytic Lymphohistiocytosis Market
Global Herbal Beauty Products Market
Global Hermetic Roof Window Market
Global High Resolution Dispensing Systems and Equipment Market
Global Homologation Market
Global Human Granulocytic Ehrlichiosis Market
Global Huntington’s Disease Market
Global Hybrid Positron Emission Tomography (PET) Systems Market
Global Hybrid Wireless Fire Detection System Market
Global Hydration Containers Market
Global Hydroxyproline Market
Global IBC Cap Market
Global Intensive Care Unit (ICU) Devices Market
Global Idle Air Control Valve Market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- [email protected]